(2S,3S,5R)-2-(3,5-Difluorophenyl)-3,5- dimethyl-2-morpholinol: A Novel Antidepressant Agent and Selective Inhibitor of Norepinephrine Uptake
- 1 January 1996
- journal article
- letter
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 39 (2) , 347-349
- https://doi.org/10.1021/jm950630p
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Synthesis and evaluation of the antidepressant activity of the enantiomers of bupropionChirality, 1993
- Antenatal screening for toxoplasmosis in the UKThe Lancet, 1990
- Pharmacological significance of the species differences in bupropion metabolismXenobiotica, 1987
- Rh blood group-specific antibodies in immune hemolytic anemia induced by nomifensineBlood, 1986
- Pharmacokinetics of bupropion and its major basic metabolites in normal subjects after a single doseClinical Pharmacology & Therapeutics, 1985
- Bupropion: A new antidepressant drug, the mechanism of action of which is not associated with down-regulation of postsynaptic β-adrenergic, serotonergic (5-HT2), α2-adrenergic, imipramine and dopaminergic receptors in brainNeuropharmacology, 1983
- Second generation antidepressants: The pharmacological and clinical significance of selected examplesDrug Development Research, 1983
- Some neurochemical properties of a new antidepressant, bupropion hydrochloride (Wellbutrin™)Drug Development Research, 1981
- Selective bromination of substituted acetophenones with dioxan dibromideAustralian Journal of Chemistry, 1973
- On the role of rate of brain norepinephrine release in the antibenzoquinolizine action of desipraminePsychopharmacology, 1965